Literature DB >> 2540636

Leukotrienes and macrophage activation: augmented cytotoxic activity and enhanced interleukin 1, tumor necrosis factor and hydrogen peroxide production.

L Gagnon1, L G Filion, C Dubois, M Rola-Pleszczynski.   

Abstract

Leukotrienes (LT), and in particular LTB4, are potent inflammatory mediators and immunomodulators. In its interactions with leukocytes, LTB4 can activate numerous functions of neutrophils and modulate the activities of various lymphocyte subsets. LTB4 can also augment macrophage and monocyte cytotoxic activities and enhance their production of hydrogen peroxide and the monokines interleukin 1 and tumor necrosis factor. These observations allow a more detailed understanding of the effects of LTB4 on cellular immune and inflammatory functions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540636     DOI: 10.1007/bf02126587

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  37 in total

1.  Immunoregulation by leukotrienes and other lipoxygenase metabolites.

Authors:  M Rola-Pleszczynski
Journal:  Immunol Today       Date:  1985-10

2.  Synergistic activation of macrophages by lymphokine and lipopolysaccharide: evidence for lymphokine as the primer and interferon as the trigger.

Authors:  R M Schultz
Journal:  J Interferon Res       Date:  1982

3.  Leukotriene B4: an inflammatory mediator in vivo.

Authors:  M A Bray; A W Ford-Hutchinson; M J Smith
Journal:  Prostaglandins       Date:  1981-08

4.  Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor.

Authors:  D O Adams; P A Marino
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

5.  Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects.

Authors:  J Ferluga; H U Schorlemmer; L C Baptista; A C Allison
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

6.  Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.

Authors:  R S Kornbluth; T S Edgington
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

7.  Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series.

Authors:  R M Schultz; N A Pavlidis; W A Stylos; M A Chirigos
Journal:  Science       Date:  1978-10-20       Impact factor: 47.728

8.  Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells.

Authors:  R Ophir; S Ben-Efraim; I L Bonta
Journal:  Int J Tissue React       Date:  1987

9.  Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.

Authors:  A R Chen; K P McKinnon; H S Koren
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.

Authors:  K Onozaki; K Matsushima; E S Kleinerman; T Saito; J J Oppenheim
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

View more
  17 in total

Review 1.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

2.  Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan.

Authors:  D D Riedel; S H Kaufmann
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  The production of oxygen metabolites and their possible regulatory role in the course of tularemia infection.

Authors:  H Kovárová; A Macela; J Stulík
Journal:  Folia Microbiol (Praha)       Date:  1990       Impact factor: 2.099

4.  Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8.

Authors:  W W Barrow; T L Davis; E L Wright; V Labrousse; M Bachelet; N Rastogi
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.

Authors:  B J R Whittle; C Varga; A Berko; K Horvath; A Posa; J P Riley; K A Lundeen; A M Fourie; P J Dunford
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

6.  Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids.

Authors:  M L Ferrándiz; S J Foster
Journal:  Agents Actions       Date:  1991-03

7.  Dihomo-gamma-linolenic acid inhibits tumour necrosis factor-alpha production by human leucocytes independently of cyclooxygenase activity.

Authors:  Maaike M B W Dooper; Boet van Riel; Yvo M F Graus; Laura M'Rabet
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

8.  Entamoeba histolytica proteins modulate the respiratory burst potential by murine macrophages.

Authors:  J Y Lin; K Keller; K Chadee
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

9.  Leukotriene B4 stimulates c-fos and c-jun gene transcription and AP-1 binding activity in human monocytes.

Authors:  J Stanková; M Rola-Pleszczynski
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

10.  Inflammation amplifies the antitumor cytostasis by human peritoneal macrophages.

Authors:  S Ben-Efraim; C Tak; M J Fieren; G J Van den Bemd; I L Bonta
Journal:  Med Oncol Tumor Pharmacother       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.